Device Recall MEDRAD Avanta Fluid Management Injection System 의 리콜

U.S. Food and Drug Administration에 따르면, 해당 리콜 는 United States 에서 Medrad Inc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    59167
  • 사례 위험등급
    Class 2
  • 사례 연번
    Z-2866-2011
  • 사례 시작날짜
    2011-06-02
  • 사례 출판 날짜
    2011-07-22
  • 사례 상황
    Terminated
  • 사례 국가
  • 사례 종료 날짜
    2012-06-05
  • 사례 출처
    USFDA
  • 사례 출처 URL
  • 비고 / 경고
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • 데이터 추가 비고
    Injector and syringe, angiographic - Product Code DXT
  • 원인
    Event was initially intended to be a product enhancement of the medrad avanta fluid management injection system. upgrades were initiated in october, 2007. observance of a possible increase in complaints and adverse event reporting resulted in the firm issuing "important product use reminder" to remind users of proper procedures for using the system and the need for diligence in reducing air embo.
  • 조치
    Medrad Inc., sent two types of "MEDICAL DEVICE FIELD CORRECTION" notifications on June 2, 2011 to all affected customers. 1. To those customers who Avanta Systems have already undergone market withdrawal and thus have been upgraded, the notification provided customer awareness that prior action should be considered a field correction. The letter stated that NO action is required since their system(s) has already been upgraded. If you have any questions, concerning these activities contact the Director of Quality Systems at (724) 940-6905. 2. To those customers whose Avanta Systems have not yet been upgraded through market withdrawal, the notification informed customers that the recalling firm is undertaking a Field Correction to upgrade their system(s). The letter included a step by step guide that will allow customers to verify that their system(s) has NOT been upgraded. Customers are instructed to complete and fax this form to MEDRAD at (412) 406-0941. If you have any questions, concerning these activities contact the Product Manager at (412) 767-2400, extension 8401.

Device

  • 모델명 / 제조번호(시리얼번호)
    Catalog numbers: AVA 500 TABL, AVA 500 PEDL
  • 의료기기 분류등급
  • 의료기기 등급
    2
  • 이식된 장치?
    No
  • 유통
    Worldwide Distribution -- (USA) (nationwide) including the state of Puerto Ricoand the countries of: AE, AL, AT, BE, BG, BR, CA, CH, CO, CY, DE, DK, DO, ES, FI, FR, GB, HK, HR, HU, IE, IL, IS, IT, JO, JP, KR, KW, LY, MA, MT, MX, MY, NL, PA, PH, PK, PT, QA, RS, RU, SA, SE, SG, SI, TR, VI, and ZA.
  • 제품 설명
    MEDRAD Avanta Fluid Management Injection System, Catalog numbers: AVA 500 TABL, AVA 500 PEDL || Product Usage: Administration of intravascular radio-opaque contrast media and common flushing solutions during angiographic procedures.
  • Manufacturer

Manufacturer

  • 제조사 주소
    Medrad Inc, 1 Medrad Dr, Indianola PA 15051-9759
  • Source
    USFDA